Mereo BioPharma Group PLC ADR (MREO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $48.71M
Last updated: Nov 17, 2026 at 4:36 PM ET
Mereo BioPharma Group PLC ADR (MREO) Stock Chart
Mereo BioPharma Group PLC ADR (MREO) has a latest price of $0.27 on Nov 17, 2026, 88.4% below its 52-week high of $2.37. Its price fell 84.6% over the past 12 months. The month-end price fell 87.1% over the 5 years through Oct 2026, a compound annual decline of 33.6%.
Price Chart
From Apr 2019 to Oct 2026, its highest month-end close was $5.60 in Apr 2019 and its lowest $0.27 in Aug 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart MREO with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MREO.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 11.9%, and over 6 months it rose 15.3%. The month-end price fell 85.6% over the 3 years through Oct 2026, a compound annual decline of 47.5%.
| Period | Change |
|---|---|
| 1 month | -9.1% |
| 3 months | -11.9% |
| 6 months | +15.3% |
| 12 months | -84.6% |
| 12 months, with dividends | -84.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -85.6% | -47.5% |
| 5 years | -87.1% | -33.6% |
Price by Year
Its best calendar year was 2023, when the price rose 208.0%, and its weakest was 2025, when it fell 88.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.29 | -30.5% |
| 2025 | $0.42 | -88.1% |
| 2024 | $3.50 | +51.5% |
| 2023 | $2.31 | +208.0% |
| 2022 | $0.75 | -53.1% |
| 2021 | $1.60 | -55.3% |
| 2020 | $3.58 | +9.1% |
Trading Range
The price is 11.8% below its 50-day average of $0.31 and 14.2% below its 200-day average of $0.32.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.27 | |
| 52-week high | $2.37 | -88.4% |
| 52-week low | $0.20 | +37.3% |
| 50-day average | $0.31 | -11.8% |
| 200-day average | $0.32 | -14.2% |
Price Risk
Over 3 years, its largest fall from a peak was 95.1%.
| Measure | Value |
|---|---|
| 1-year beta | 1.70 |
| Largest fall, 1 year | -89.7% |
| Largest fall, 3 years | -95.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About MREO
What is MREO's 1-year price change?
Mereo BioPharma Group PLC ADR's price fell 84.6% over the past 12 months. With dividends included, the 12-month total return was -84.6%.
What is MREO's 5-year price change?
Mereo BioPharma Group PLC ADR's month-end price fell 87.1% over the 5 years through Oct 2026, a compound annual decline of 33.6%. These figures leave out dividends.
What is MREO's 52-week high and low?
Mereo BioPharma Group PLC ADR's 52-week high is $2.37 and its 52-week low is $0.20. Its latest price of $0.27 on Nov 17, 2026 is 88.4% below the high.
What is MREO's beta?
Mereo BioPharma Group PLC ADR's 1-year beta against the S&P 500 is 1.70, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 89.7%.
Is the MREO chart free?
Yes. Advanced Charting for MREO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
MREO pages: Overview, Charting, Statistics, Valuation, Competitors